New radiation technique may spare bowel in cervical cancer treatment
NCT ID NCT01279135
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial tested whether a newer, more precise type of radiation (image-guided intensity modulated radiotherapy) could reduce long-term bowel problems compared to standard radiation in 300 women who had surgery for cervical cancer. The study focused on lowering severe bowel side effects that can occur months or years after treatment. Results could help doctors choose the best radiation approach to improve quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Radiation therapy (image-guided intensity modulated radiotherapy vs conventional radiotherapy)
- What this could lead to
- If successful, this could establish a new standard of care that reduces long-term bowel damage for women receiving radiation after cervical cancer surgery.
- What could go wrong
- This trial is completed, but results may not apply to all patients or settings. The benefit may be modest, and some side effects may still occur.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER CERVIX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
Navi Mumbai, Maharashtra, 410210, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.